1. Methotrexate in acute persistent humoral rejection: an option for graft rescue 
Fernando Bacal, MD, Gustavo L Sodré, MD, Daniela A Fernandes, MD, Vera D Aiello, MD, Noedir Stolf, MD, Edimar Bocchi, MD, Giovanni Bellotti, MD 
The Annals of Thoracic Surgery 
Volume 76, Issue 2, Pages (August 2003)
DOI: /S (03)

2. Fig 1
Immunofluorescence of myocardial tissue: (A) Focal positivity for immunoglobulin G in a small vessel (white arrow) (original magnification, ×400.) (B) Granular pattern of positivity for C3 in the interstitium (original magnification, ×400.) (C) Diffuse positivity for fibrinogen in the interstitium (original magnification, ×200).
The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3. Fig 2
Immunosuppression therapy used to treat the rejection in a patient with persistent cellular and humoral components. (ATGAM = polyclonal antibodies; FK506 =tacrolimus; MMF =mycophenolate mofetil; OKT3 = monoclonal antibodies; Rej = rejection.)
The Annals of Thoracic Surgery  , DOI: ( /S (03) )